Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.
Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.
Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024
| Title | Type | Presenter | Session | ||
|---|---|---|---|---|---|
 | : RELATIVE RATES OF COMPLETE SYMPTOM RELIEF IN DEPRESSED PATIENTS TREATED WITH VENLAFAXINE OR SSRIS | Encore Presentation | |||
| A DECISION ANALYTIC MODEL OF THE ECONOMIC BENEFITS OF REMISSION: COMPARISON OF VENLAFAXINE AND SSRIS | Original Research | |||
| A NATURALISTIC TRIAL WITH ARIPIPRAZOLE IN A GENERAL PSYCHIATRIC SETTING | Encore Presentation | |||
| A WELLNESS INTERVENTION PROGRAM FOR PATIENTS WITH SERIOUS AND PERSISTENT MENTAL ILLNESS | Best Practices | |||
| Antiandrogens as a Treatment of Aggression: A Case Series | Work in Progress | |||
| Antidepressant Induced Apathy | Work in Progress | |||
| ARIPIPRAZOLE vs PERPHENAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA | Encore Presentation | |||
| ARIPIPRAZOLE vs PLACEBO IN ACUTE MANIA: RESULTS FROM A SECOND STUDY | Encore Presentation | |||
| ARIPIPRAZOLE vs PLACEBO IN ACUTE MANIA: SAFETY AND TOLERABILITY POOLED ANALYSIS | Encore Presentation | |||
| ATOMOXETINE AND METHYLPHENIDATE EFFECTS ON SLEEP IN CHILDREN WITH ADHD | Original Research | |||
| ATOMOXETINE EFFICACY FOR SEVERE HYPERACTIVE AND INATTENTIVE ADHD SYMPTOMS | Original Research | |||
| Atypical Antipsychotic Medication Compliance in a Schizophrenia Population | Original Research | |||
| Beneficial Psychiatric Effects Secondary to Levetiracetam Therapy in the Developmentally Delayed Population: A Case Series Report | Original Research | |||
| BIOAVAILABILITY OF AN ORAL SOLUTION OF THE ANTIPSYCHOTIC ARIPIPRAZOLE | Original Research | |||
| Clinical Outcomes of a Self-Medication Education and Behavioral Training Program for Severely Mentally Ill Veterans | Work in Progress | |||
| COMPARISON OF MEDICATION ADHERENCE RATES AMONG PATIENTS RECEIVING ANTIPSYCHOTIC AGENTS | Original Research | |||
| COMPARISON OF OLANZAPINE AND LITHIUM TREATMENT GROUPS BASED ON LITHIUM BLOOD LEVELS: A 52-WEEK BIPOLAR RELAPSE PREVENTION STUDY | Original Research | |||
| COMPLETE RESOLUTION OF SOMATIC SYMPTOMS OF DEPRESSION WITH VENLAFAXINE OR SSRIS | Encore Presentation | |||
| Cost Savings in Switching From Wellbutrin SR (R) to Generic Bupropion at Alaska Native Medical Center | Original Research | |||
| DEFINITIVE EVIDENCE THAT ARIPIPRAZOLE IS A D2 AND 5-HT1A PARTIAL AGONIST | Encore Presentation | |||
| Development of a Customized Database to Document Psychiatric Clinical Pharmacist Recommendations | Best Practices | |||
| Differences Among Antipsychotics in the Time to All-Cause Drug Discontinuation: Results from a Longitudinal Naturalistic Study of Schizophrenia. | Original Research | |||
| Direct and indirect cost savings associated with adding Risperdal® M-Tab™ to a university medical center formulary | Original Research | |||
| DULOXETINE IN THE TREATMENT OF THE PAIN ASSOCIATED WITH DIABETIC NEUROPATHY | Encore Presentation | |||
| DULOXETINE VS PLACEBO IN THE PREVENTION OF RELAPSE OF MAJOR DEPRESSIVE DISORDER | Encore Presentation | |||
| EFFECT OF ATOMOXETINE IN TREATING PEDIATRIC ADHD IN A NATURAL SETTING | Original Research | |||
| Effect of bupropion on cytochrome P450 2D6 (CYP2D6) activity | Original Research | |||
| EFFECT OF OLANZAPINE/FLUOXETINE ON CORE MOOD SYMPTOMS IN BIPOLAR DEPRESSION | Original Research | |||
| EFFECTS OF RENAL AND HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF ARIPIPRAZOLE | Encore Presentation | |||
| EFFECTS OF TIME OF DOSING AND FOOD ON ARIPIPRAZOLE PHARMACOKINETICS | Encore Presentation | |||
| Electrocardiographic Evaluation of Ziprasidone Intramuscular Formulation in Children | Work in Progress | |||
| EMOTIONAL AND PAINFUL PHYSICAL SYMPTOMS ASSOCIATED WITH DEPRESSION RESPOND TO DULOXETINE, A DUAL ACTION SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR | Original Research | |||
| Evaluation of a Pharmacy Intervention in Geriatric Assisted Living Facility Residents | Work in Progress | |||
| Evaluation of Medication Adherence and Healthcare Utilization in the Psychiatric Population | Original Research | |||
| EVALUATION OF THE DRUG INTERACTION POTENTIAL OF CITALOPRAM (C) COMPARED TO PAROXETINE (P) AND FLUOXETINE (F) ON CYP2D6 USING DEXTROMETHORPHAN (DM) PROBE METHODOLOGY | Original Research | |||
| Extended-Release Divalproex for Mood Stabilization | Encore Presentation | |||
| FASTING GLUCOSE AND LIPIDS IN SCHIZOPHRENIC PATIENTS TREATED WITH OLANZAPINE OR ZIPRASIDONE | Encore Presentation | |||
| GUANFACINE AUGMENTATION FOR THE REMEDIATION OF ATTENTION | Work in Progress | |||
| IMPROVEMENT IN DEPRESSION-RELATED FATIGUE AMONG PATIENTS TREATED WITH VENLAFAXINE, SSRIS, OR PLACEBO | Original Research | |||
| IMPROVEMENT OF COMORBID DEPRESSION WITH OLANZAPINE VERSUS ZIPRASIDONE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER | Encore Presentation | |||
| INTRAMUSCULAR ARIPIPRAZOLE IN ACUTELY AGITATED PSYCHOTIC PATIENTS | Original Research | |||
| Is It Safe for My Baby?: The re-development of a popular resource about the risks and recommendations for the use of medication, alcohol, tobacco and other drugs during pregnancy and breastfeeding. | Best Practices | |||
| LAMOTRIGINE THERAPY IN PATIENTS WITH MENTAL RETARDATION AND REFRACTORY EPILEPSY IN INSTITUTIONAL AND HOME SETTINGS | Encore Presentation | |||
| LONG-TERM EFFICACY OF ARIPIPRAZOLE IN THE MAINTENANCE TREATMENT OF BIPOLAR DISORDER | Encore Presentation | |||
| MEMANTINE IS SAFE FOR SHORT- AND LONG-TERM TREATMENT OF DEMENTIA | Encore Presentation | |||
| MEMANTINE MONOTHERAPY IS EFFECTIVE AND SAFE FOR THE TREATMENT OF MILD TO MODERATE ALZHEIMER\'S DISEASE: A RANDOMIZED CONTROLLED TRIAL | Encore Presentation | |||
| Monitoring of Adherence to Ziprasidone Contraindications | Original Research | |||
| OLANZAPINE COMPARED TO OTHER ATYPICALS: RELAPSE PREVENTION IN SCHIZOPHRENIA | Encore Presentation | |||
| Open Label Withdrawal of Antipsychotic Drugs from Patients with Schizophrenia Treated Concomitantly with Atypicals Antipsychotics Drugs | Work in Progress | |||
| Oral SAMe and Lack of Toxicity | Original Research | |||
| PATIENTS TREATED WITH QUETIAPINE DEVELOP TOLERANCE TO SOMNOLENCE: PRECLINICAL MECHANISM AND CLINICAL EVIDENCE | Original Research | |||
| Pharmacoeconomic Considerations of Polypharmacy with Psychotropic Medications | Work in Progress | |||
| Pharmacy students on psychiatry rotations - a unique instructional activity | Best Practices | |||
| PRELIMINARY PHARMACOKINETICS AND TOLERABILITY OF HIGHER DOSE OLANZAPINE | Encore Presentation | |||
| Prevalence and motivations for the illicit use of prescription stimulants in an undergraduate student sample. | Original Research | |||
| Psychiatric Effects Associated with Efavirenz: A Retrospective Study | Encore Presentation | |||
| PSYCHOTROPIC-INDUCED WEIGHT GAIN AND QUALITY OF LIFE ASSESSMENT IN PSYCHIATRIC PATIENTS OF A VETERAN’S AFFAIRS HOSPITAL IN SOUTH AUSTRALIA | Work in Progress | |||
| Risk of Rehospitalization: Olanzapine versus Quetiapine | Original Research | |||
| SAFETY AND TOLERABILITY PROFILE OF ARIPIPRAZOLE IN ELDERLY PATIENTS WITH PSYCHOSIS OF ALZHEIMER’S DISEASE: A POOLED ANALYSIS | Original Research | |||
| SAFETY OF INTRAMUSCULAR OLANZAPINE IN COMORBIDLY ILL, ACUTELY AGITATED PATIENTS WITH DEMENTIA | Original Research | |||
| SHORT-TERM TREATMENT OF PTSD WITH VENLAFAXINE XR, SERTRALINE, AND PLACEBO | Encore Presentation | |||
| Stability Of Clozapine In Oral Suspension | Encore Presentation | |||
| The association of metabotropic glutamate receptor 3 (GRM3) gene polymorphisms with clinical response to olanzapine | Work in Progress | |||
| The Cost of Severe Agiation at a State psychiatric Hospital | Original Research | |||
| THE EFFECTS OF SWITCHING ANTIPSYCHOTICS ON LIPIDS: A RETROSPECTIVE CHART REVIEW | Encore Presentation | |||
| THE EFFICACY AND SAFETY OF QUETIAPINE VERSUS DIVALPROEX SODIUM IN THE TREATMENT OF BIPOLAR MANIA | Encore Presentation | |||
| THE IMPACT OF TOPIRAMATE ON SERUM BICARBONATE CONCENTRATIONS IN ADULT PATIENTS RECEIVING ANTIEPILEPTIC THERAPY | Original Research | |||
| THE INFLUENCE OF STUDY DESIGN ON THE RESULTS OF PHARMACOEPIDEMIOLOGIC STUDIES OF DIABETES RISK WITH ANTIPSYCHOTIC THERAPY | Original Research | |||
| The long-term impact of group attendance, function and psychotropic medications on weight loss in a pharmacy-based weight management clinic in psychiatry. | Best Practices | |||
| The Rate of Adherence with Atypical Antipsychotics Among Schizophrenic Patients | Work in Progress | |||
| TREATMENT OF CHRONIC PAIN WITH VENLAFAXINE XR | Encore Presentation | |||
| Treatment Patterns and Medication Costs of Bipolar Disorder Compared to Schizophrenia and Unipolar Depression | Original Research | |||
| UTILIZATION ANALYSIS OF HEALTHCARE RESOURCES FOR PATIENTS TREATED WITH ATYPICAL ANTIPSYCHOTICS | Original Research | |||
| VENLAFAXINE XR IN THE TREATMENT OF PANIC DISORDER | Encore Presentation |